These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 26165070

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Potassium-competitive acid blockers: Advanced therapeutic option for acid-related diseases.
    Inatomi N, Matsukawa J, Sakurai Y, Otake K.
    Pharmacol Ther; 2016 Dec; 168():12-22. PubMed ID: 27514776
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Optimal use of proton pump inhibitors for treating acid peptic diseases in primary care.
    Tack J, Louis E, Persy V, Urbain D.
    Acta Gastroenterol Belg; 2013 Dec; 76(4):393-402. PubMed ID: 24592542
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Evidence and uncertainties on the clinical use of proton pump inhibitors].
    de Prados CM.
    Gastroenterol Hepatol; 2010 May; 33 Suppl 1():5-10. PubMed ID: 20728783
    [Abstract] [Full Text] [Related]

  • 7. Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease.
    Okuyama M, Nakahara K, Iwakura N, Hasegawa T, Oyama M, Inoue A, Ishizu H, Satoh H, Fujiwara Y.
    Digestion; 2017 May; 95(4):281-287. PubMed ID: 28501868
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Therapeutic trends of diseases of the upper gastrointestinal tract in patients with negative H. pylori status].
    Watari J, Sakurai J, Morita T, Oshima T, Hori K, Miwa H.
    Nihon Rinsho; 2009 Dec; 67(12):2378-86. PubMed ID: 19999128
    [Abstract] [Full Text] [Related]

  • 15. Proton pump inhibitors: the good, the bad, and the unwanted.
    Chubineh S, Birk J.
    South Med J; 2012 Nov; 105(11):613-8. PubMed ID: 23128806
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potassium-competitive Acid Blockers: Current Clinical Use and Future Developments.
    Scarpignato C, Hunt RH.
    Curr Gastroenterol Rep; 2024 Nov; 26(11):273-293. PubMed ID: 39145848
    [Abstract] [Full Text] [Related]

  • 18. Acid suppression therapy: where do we go from here?
    Scarpignato C, Pelosini I, Di Mario F.
    Dig Dis; 2006 Nov; 24(1-2):11-46. PubMed ID: 16699262
    [Abstract] [Full Text] [Related]

  • 19. Rapid metabolizer genotype of CYP2C19 is a risk factor of being refractory to proton pump inhibitor therapy for reflux esophagitis.
    Ichikawa H, Sugimoto M, Sugimoto K, Andoh A, Furuta T.
    J Gastroenterol Hepatol; 2016 Apr; 31(4):716-26. PubMed ID: 26580676
    [Abstract] [Full Text] [Related]

  • 20. [Inadequate response to proton pump inhibitor therapy: causes and patient management tactics].
    Evsyutina YV, Trukhmanov AS.
    Ter Arkh; 2015 Apr; 87(2):85-89. PubMed ID: 25864356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.